A Plus Biotechnology Corporation Limited

A Plus Biotechnology Corporation Limited, established in 2009, is a leading provider of orthopedic medical solutions, focusing on the design, development, and manufacture of orthopedic implants and patient-specific instruments (PSI). The company specializes in anatomical locking plates, high tibial osteotomy (HTO) systems, and biologics tailored to Asian bone structures, serving industries such as orthopedics and regenerative medicine. Collaborating with academic and clinical institutions across Taiwan and Asia, it enhances products based on clinical feedback. Certified with ISO 13485, A Plus holds multiple patents and serves global clients, emphasizing precision and innovation in surgical automation. Its PSI systems integrate clinical imaging and digital modeling to reduce surgery time and complications, supporting advanced medical procedures.